Back to search

Norway· NO-ID_A26E19DB-59D2-45D5-ABD3-98C3F9264D63

Rosuvastatin Glenmark

A rosuvastatin product containing rosuvastatin, registered in Norway by Glenmark Arzneimittel GmbH. The same ATC class is registered in 18 of our 19 countries.

ATC C10AA07

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedRosuvastatin GlenmarkATCC10AA07REGISTER NO.NO-ID_A26E19DB-59D2-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Rosuvastatin is registered in 18 of 19 countries.

Countries holding a registration under ATC C10AA07 (rosuvastatin), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 11 of them publish a price we can compare per daily dose

Rosuvastatin · ATC C10AA07

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of rosuvastatin costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.036 in United States to $0.73 in Switzerland — a ×20 gap.

  • 5 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Rosuvastatin · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.73
  • ES Spain$0.39
  • IT Italy$0.26
  • FR France$0.17
  • US United States$0.036 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Rosuvastatin
Manufacturer
Glenmark Arzneimittel GmbH
Country
Norway (NO)
ATC code
C10AA07
ATC class
Rosuvastatin
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • no_varenummer
    197261
    100
    NOK 327.1
  • gtin
    7350109550016
  • no_merkevare_id
    ID_A26E19DB-59D2-45D5-ABD3-98C3F9264D63

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

689 interactions on record for rosuvastatin.

Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Rosuvastatin · interactions on record

689 records

  • 29 severe
  • 200 moderate
  • 20 minor
  • 403 info

Most severe, free to view

  • ClofibrateC10AB01severe
  • GemfibrozilC10AB04severe
  • FenofibrateC10AB05severe
  • MipomersenC10AX11severe

37 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rosuvastatin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rosuvastatin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Arosuva, Crestor
  • Belgium · Crestor, Rosuvastatin Ab
  • Bulgaria · Rossta, Rosuvastatin Viatris
  • Cyprus · Artepro, Celmantin
  • Czechia · Corvapro Neo, Mertenil
  • Germany · Crestor, Rosuvador
  • Denmark · Celmantin, Crestor
  • Estonia · Crestor, Rosucard
  • Spain · Abemax, Alcotina
  • Finland · Crestor, Rosuvastatin Actavis
  • France · Crestor, Rosuvastatine Almus
  • United Kingdom (Northern Ireland) · Crestor, Enebium
  • Greece · Celmantin, Crestilen
  • Croatia · Corvapro, Corvapro Neo
  • Hungary · Delipid, Ropuido
  • Ireland · Crestor, Rosuva
  • Iceland · Platorel, Rosuvastatin Actavis
  • Italy · Borghes, Colcardiol
  • Lithuania · Crestor, Rosuvacard
  • Luxembourg · Crestor, Rosuvastatin Micro Labs
  • Latvia · Crestor, Rosuvacard
  • Malta · Celmantin, Corvapro Neo
  • Netherlands · Crestor, Provisacor
  • Poland · Aporoza, Crosuvo
  • Portugal · Crestor, Crestor 10mg Ip
  • Romania · Crestor, Rosi
  • Sweden · Crestor, Rosuvastatin Glenmark
  • Slovenia · Celmantin, Coupet
  • Slovakia · Provacor, Rosucard

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dc085a32-71b7-4508-9c41-a34c91a63de4
GET /v1/drugs/dc085a32-71b7-4508-9c41-a34c91a63de4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett, filmdrasjert",
  "source": "fest",
  "status": "A",
  "atc_name": "Rosuvastatin",
  "merkevare_id": "ID_A26E19DB-59D2-45D5-ABD3-98C3F9264D63",
  "name_form_strength": "Rosuvastatin Glenmark tab 10 mg",
  "prescription_group": "C"
}

See everything about rosuvastatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.